• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ADMA

ADMA

ADMA Biologics, Inc.

NASDAQHealthcareBiotechnologyUS

USD7.76

+0.16 (+2.11%)

Rating:B

Company Profile

CEO

Adam S. Grossman

IPO Date

2013-10-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$7.53

Prev. Close

$7.60

Day Low

$7.46

Day High

$7.79

52W Low

$7.21

52W High

$22.37

Market Cap

$1.80B

Volume

2.81M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

52.7%

Avg Negative

2.9%

Avg Neutral

44.3%

News Feed

ADMA Biologics: Getting Unstuck Between A Rock And A Hard Place

Seeking Alpha·5/17/2021·↑ positive

ADMA Biologics Inc. (ADMA) CEO Adam Grossman on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/12/2021·↓ negative

Recap: ADMA Biologics Q1 Earnings

Benzinga·5/12/2021·↑ positive

ADMA Biologics Earnings Preview

Benzinga·5/11/2021·↓ negative

Why ADMA Biologics (ADMA) Might Surprise This Earnings Season

Zacks Investment Research·5/10/2021·↑ positive

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

GlobeNewsWire·5/5/2021·↓ negative

ADMA Stock: The Big FDA News Boosting ADMA Biologics Today

InvestorPlace·4/28/2021·↑ positive

Penny Stocks Are Back; Here's 3 to Watch Right Now

PennyStocks·4/28/2021·↑ positive

ADMA Biologics Shares Jump On Increased Manufacturing Capacity For Intravenous Immune Globulin

Benzinga·4/28/2021·↑ positive

ADMA Stock: Over 20% Increase Pre-Market Explanation

Pulse2·4/28/2021·↑ positive